众生药业：公司正积极推进ZSP1601片IIb期临床试验

Core Viewpoint - The company is actively advancing the clinical trial of ZSP1601 tablets and aims to complete the research and apply for drug approval to provide more treatment options for patients [1] Group 1 - The company responded to investor inquiries regarding the data release timeline for ZSP1601 [1] - The company is currently in the IIb phase of the clinical trial for ZSP1601 tablets [1] - The company is committed to completing the relevant research as soon as possible [1]